Sally Bennett
Förmögenhet: 3 981 $ per 2026-09-30
Förmögenhet: 3 981 $ per 2026-09-30
Sally Bennett is currently Director at Mosaic Therapeutics Ltd. and P4 Precision Medicine Accelerator.
The current roles also include Independent Member-Supervisory Board at Innate Pharma SA since 2022, Member at The Institute of Directors, and Member-Governors Council at University College London Hospitals NHS Foundation Trust.
Former roles include Independent Non-Executive Director at Oncoinvent ASA, Analyst at ING Bank NV (United Kingdom), Senior Member at HealthCor Management LP, Senior Research Analyst at Piper Sandler Ltd. from 2006 to 2007, and Analyst at Healthcor Management UK LLP from 2008 to 2014.
Education includes undergraduate and doctorate degrees from The University of Manchester.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-30 | 2 500 ( 0 % ) | 3 981 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| INNATE PHARMA | Direktör/Styrelseledamot | 2022-05-20 |
The Institute of Directors
The Institute of Directors Miscellaneous Commercial ServicesCommercial Services Provides informative events and professional development courses | Företagsledare/Principal | - |
University College London Hospitals NHS Foundation Trust
University College London Hospitals NHS Foundation Trust Hospital/Nursing ManagementHealth Services Operates hospitals | Företagsledare/Principal | - |
P4 Precision Medicine Accelerator
P4 Precision Medicine Accelerator Miscellaneous Commercial ServicesCommercial Services Develops health organization program | Direktör/Styrelseledamot | - |
Mosaic Therapeutics Ltd.
Mosaic Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Discovers and develops novel targeted therapies using computational methods and next-generation cancer models | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
Healthcor Management UK LLP
Healthcor Management UK LLP Investment ManagersFinance Alternative investment manager | Analyst-Equity | 2014-07-02 |
Piper Sandler Ltd.
Piper Sandler Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2007-04-30 |
HealthCor Management LP
HealthCor Management LP Investment ManagersFinance HealthCor focuses principally on the global healthcare and life sciences industry. The firm seeks to achieve superior risk-adjusted returns primarily through investments in equity and equity-related instruments where they use a fundamental bottom-up research driven approach to stock selection across the major sub-sectors of healthcare and life sciences including pharmaceuticals, MedTech, biotech and services. | Företagsledare/Principal | - |
| ONCOINVENT ASA | Direktör/Styrelseledamot | - |
| ░░░ ░░░░ ░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
ING Bank NV (United Kingdom)
ING Bank NV (United Kingdom) Investment Banks/BrokersFinance Provides brokerage services | Finance |
HealthCor Management LP
HealthCor Management LP Investment ManagersFinance HealthCor focuses principally on the global healthcare and life sciences industry. The firm seeks to achieve superior risk-adjusted returns primarily through investments in equity and equity-related instruments where they use a fundamental bottom-up research driven approach to stock selection across the major sub-sectors of healthcare and life sciences including pharmaceuticals, MedTech, biotech and services. | Finance |
Piper Sandler Ltd.
Piper Sandler Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
The Institute of Directors
The Institute of Directors Miscellaneous Commercial ServicesCommercial Services Provides informative events and professional development courses | Commercial Services |
Healthcor Management UK LLP
Healthcor Management UK LLP Investment ManagersFinance Alternative investment manager | Finance |
BerGenBio ASA
BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
University College London Hospitals NHS Foundation Trust
University College London Hospitals NHS Foundation Trust Hospital/Nursing ManagementHealth Services Operates hospitals | Health Services |
P4 Precision Medicine Accelerator
P4 Precision Medicine Accelerator Miscellaneous Commercial ServicesCommercial Services Develops health organization program | Commercial Services |
Mosaic Therapeutics Ltd.
Mosaic Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Discovers and develops novel targeted therapies using computational methods and next-generation cancer models | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån